211 related articles for article (PubMed ID: 24586244)
1. Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis.
Ghassemi R; Narayanan S; Banwell B; Sled JG; Shroff M; Arnold DL;
PLoS One; 2014; 9(2):e85741. PubMed ID: 24586244
[TBL] [Abstract][Full Text] [Related]
2. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Measurement of tissue damage and recovery within new T2w lesions in pediatric- and adult-onset multiple sclerosis.
Ghassemi R; Brown R; Banwell B; Narayanan S; Arnold DL;
Mult Scler; 2015 May; 21(6):718-25. PubMed ID: 25480858
[TBL] [Abstract][Full Text] [Related]
4. Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis.
Tauhid S; Chu R; Sasane R; Glanz BI; Neema M; Miller JR; Kim G; Signorovitch JE; Healy BC; Chitnis T; Weiner HL; Bakshi R
J Neurol; 2015 Nov; 262(11):2425-32. PubMed ID: 26205635
[TBL] [Abstract][Full Text] [Related]
5. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.
van Walderveen MA; Lycklama A Nijeholt GJ; Adèr HJ; Jongen PJ; Polman CH; Castelijns JA; Barkhof F
Arch Neurol; 2001 Jan; 58(1):76-81. PubMed ID: 11176939
[TBL] [Abstract][Full Text] [Related]
6. Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis.
Filli L; Hofstetter L; Kuster P; Traud S; Mueller-Lenke N; Naegelin Y; Kappos L; Gass A; Sprenger T; Nichols TE; Vrenken H; Barkhof F; Polman C; Radue EW; Borgwardt SJ; Bendfeldt K
Mult Scler; 2012 Nov; 18(11):1577-84. PubMed ID: 22495945
[TBL] [Abstract][Full Text] [Related]
7. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
[TBL] [Abstract][Full Text] [Related]
8. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
[TBL] [Abstract][Full Text] [Related]
9. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
[TBL] [Abstract][Full Text] [Related]
10. Lesion distribution in children with clinically isolated syndromes.
Ghassemi R; Antel SB; Narayanan S; Francis SJ; Bar-Or A; Sadovnick AD; Banwell B; Arnold DL;
Ann Neurol; 2008 Mar; 63(3):401-5. PubMed ID: 18306242
[TBL] [Abstract][Full Text] [Related]
11. ADvanced IMage Algebra (ADIMA): a novel method for depicting multiple sclerosis lesion heterogeneity, as demonstrated by quantitative MRI.
Yiannakas MC; Tozer DJ; Schmierer K; Chard DT; Anderson VM; Altmann DR; Miller DH; Wheeler-Kingshott CA
Mult Scler; 2013 May; 19(6):732-41. PubMed ID: 23037551
[TBL] [Abstract][Full Text] [Related]
12. Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale.
Bakshi R; Neema M; Healy BC; Liptak Z; Betensky RA; Buckle GJ; Gauthier SA; Stankiewicz J; Meier D; Egorova S; Arora A; Guss ZD; Glanz B; Khoury SJ; Guttmann CR; Weiner HL
Arch Neurol; 2008 Nov; 65(11):1449-53. PubMed ID: 19001162
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Multiple Sclerosis Cortical Lesion Types Detected by Multicontrast 3T and 7T MRI.
Maranzano J; Dadar M; Rudko DA; De Nigris D; Elliott C; Gati JS; Morrow SA; Menon RS; Collins DL; Arnold DL; Narayanan S
AJNR Am J Neuroradiol; 2019 Jul; 40(7):1162-1169. PubMed ID: 31221631
[TBL] [Abstract][Full Text] [Related]
14. Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability.
Paolillo A; Pozzilli C; Gasperini C; Giugni E; Mainero C; Giuliani S; Tomassini V; Millefiorini E; Bastianello S
J Neurol Sci; 2000 Mar; 174(2):85-91. PubMed ID: 10727693
[TBL] [Abstract][Full Text] [Related]
15. CEST 2022 - Differences in APT-weighted signal in T1 weighted isointense lesions, black holes and normal-appearing white matter in people with relapsing-remitting multiple sclerosis.
Khormi I; Al-Iedani O; Casagranda S; Papageorgakis C; Alshehri A; Lea R; Liebig P; Ramadan S; Lechner-Scott J
Magn Reson Imaging; 2023 Oct; 102():212-221. PubMed ID: 37321380
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
[TBL] [Abstract][Full Text] [Related]
17. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
Boster A; Hreha S; Berger JR; Bao F; Penmesta R; Tselis A; Endress C; Zak I; Perumal J; Caon C; Vazquez J; Tyler KL; Racke MK; Millis S; Khan O
Arch Neurol; 2009 May; 66(5):593-9. PubMed ID: 19433659
[TBL] [Abstract][Full Text] [Related]
18. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.
Pascual AM; Martínez-Bisbal MC; Boscá I; Valero C; Coret F; Martínez-Granados B; Marti-Bonmati L; Mir A; Celda B; Casanova B
Neurology; 2007 Jul; 69(1):63-7. PubMed ID: 17606882
[TBL] [Abstract][Full Text] [Related]
19. Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.
La Mantia L; Di Pietrantonj C; Rovaris M; Rigon G; Frau S; Berardo F; Gandini A; Longobardi A; Weinstock-Guttman B; Vaona A
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009333. PubMed ID: 27880972
[TBL] [Abstract][Full Text] [Related]
20. Lesion-Specific Metabolic Alterations in Relapsing-Remitting Multiple Sclerosis Via 7 T Magnetic Resonance Spectroscopic Imaging.
Lipka A; Niess E; Dal-Bianco A; Hangel GJ; Rommer PS; Strasser B; Motyka S; Hingerl L; Berger T; Hnilicová P; Kantorová E; Leutmezer F; Kurča E; Gruber S; Trattnig S; Bogner W
Invest Radiol; 2023 Feb; 58(2):156-165. PubMed ID: 36094811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
